Monday, 30 March 2015

Electroconvulsive therapy changes key areas of the human brain that play a role in memory, emotion






Katherina Narr, PhD. Credit: UCLA

Although scientists know that depression affects the brain, they don't know why some people respond to treatment while others do not.



Now a team of UCLA researchers has shown for the first time in a large cohort of patients that electroconvulsive therapy (ECT), sometimes referred to as shock , change certain areas of the brain that play a role in how people feel, learn and respond to positive and negative environmental factors. The team imaged the hippocampus and amgydalar in patients before, during and after undergoing ECT and compared those images to healthy control subjects.


They also showed that the hippocampus changes, or increases in size, correlated to improved mood in patients with major depression and indicated how well they were responding to treatment. Additionally, using leading-edge methods to look at brain shape, the team showed that parts of these structures change more with treatment, providing vital clues to how the connections in the brain may be used to select for patients who will respond well to treatment.


That would also result in sparing those patients who won't respond from months of taking drugs that ultimately won't work for them, said study senior author Katherine L. Narr, an associate professor of neurology.


"Major depression is common, affects all ages, races and ethnic groups and has a serious consequence on people's family lives and work," Narr said. "People with depression also are at higher risk for suicide, which accounts for more deaths than car accidents, natural disasters and war each year on average. Unfortunately, standard types of medication used to treat major depression take a long time to work, and for at least a third of people, the medication will not work well enough to provide any real help."


The study appears in the early online edition of the peer-reviewed journal Biological Psychiatry.


ECT, which has been used for more than 50 years, carries with it a certain stigma. However, within the last decade, advances in anesthesia, electrical stimulation equipment and new evidence about electrode lead placement have improved safety and reduced side effects, said study first author Shantanu H. Joshi, an assistant professor of neurology.


Further advances in high-resolution MRI also allow the measurement of the induced brain changes with improved accuracy and precision.


"ECT has been shown to be very effective for treating patients with who don't respond well to other treatments," Joshi said. "During the treatment course, ECT leads to plastic changes in the brain that are linked with improvements in mood. Specifically, we saw the hippocampus and amygdala - important for memory and emotion - are shown to increase in size. People with smaller hippocampal size prior to starting treatment are less likely to respond as well to treatment. While our research investigates structural neuroplasticity in depression in response to ECT, our findings are considered to be of much broader interest to the field."


In addition to ECT, the team expects that the effects shown would extend to more standard, less rapidly acting antidepressant treatments and could be used to predict patient response.


In this study, the team imaged 43 patients undergoing ECT at three time points, before beginning treatment, after the second ECT session and within one week of completing treatment, resulting in 129 brain scans. They also imaged 32 healthy controls twice, and compared those images to the ECT patients.


Going forward, the UCLA team will examine the relationship between the hippocampal structural neuroplasticity and its neurochemistry in terms of the metabolite response, which has important implications for understanding the brain's metabolic regulation and the excitation and suppression as a response to ECT. Additionally, the hippocampal and amgydalar shape will be used as features for classification and prediction of depression diagnosis and treatment response using advanced machine-learning techniques. The changes in the hippocampal and the amgydalar structure will be further investigated with regards to novel disease maintenance treatments along with relapse/recurrence rates.


Major affects 350 million people each year and leads to enormous personal suffering, loss of productivity and is aburden to family, the health care system and the economy. Finding better ways to select patients for treatments that will alleviate their symptoms would go a long way to reducing that suffering, Narr said.


"Our findings newly show that hippocampal structure prior to ECT may be an important indicator of treatment outcome," the study states. "That is, with smaller hippocampal volumes at baseline are shown to more likely exhibit increases in volume with ECT and to show concomitant improvements in clinical symptoms. Results further indicate that both clinical response to ECT and ECT-induced changes in volume occur rapidly."



Medical Xpress on facebook


Related Stories


Researchers look at therapeutic benefits of ketamine


date May 01, 2013

The largest trial into the use of Electroconvulsive Therapy (ECT) in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe ...



Declining access to electroconvulsive therapy: A clinical choice or an economic one?


date Jan 10, 2013

Horrific images from One Flew Over the Cuckoo's Nest notwithstanding, modern electroconvulsive therapy (ECT) remains one of the safest and most effective antidepressant treatments, particularly for patients who do not tolerate ...



New depression treatment may avoid side effects


date Oct 23, 2012

In an Australian first, researchers are studying Magnetic Seizure Therapy (MST) as an alternative treatment for the 30 per cent of patients suffering from depression who don't respond to traditional treatment.



Researchers find ECT can rid the mind of selected memory


date Dec 23, 2013

(Medical Xpress)—A team of researchers working in the Netherlands has found that partial selective memory deletion can be achieved using Electroconvulsive Therapy (ECT). In their paper published in the journal ...



ECT can restore quality of life for some severely depressed patients


date Apr 15, 2013

Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.





Recommended for you



Publication bias and 'spin' raise questions about drugs for anxiety disorders


date 22 minutes ago

A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.




What is the best measure of depression severity in adolescents?


date 4 hours ago

At present the key symptom for diagnosing major depressive disorder (MDD) in adolescents is irritability. However a new study has found that the severity of anhedonia (the inability to gain pleasure from ...




Classroom behaviour and dyslexia research


date 6 hours ago

Bournemouth University lecturer Dr Julie Kirkby is investigating the significance of copying and note-taking in the classroom and how it affects the learning of Dyslexic children.




We all feel disgust but why do some of us turn it on ourselves?


date 6 hours ago

Disgust is a universal emotion – we all get disgusted by things, just as we all experience other "basic" emotions, such as happiness and sadness. Disgust has many functions. It protects us from products ...




Study finds vast regional differences in personality within the UK


date 7 hours ago

How exactly do we become the people we are? A study published earlier this week found that there are vast regional differences in personality within the UK. ...




Hormone level predicts how the brain processes social information


date 7 hours ago

The hormone oxytocin is made at different levels in different people and it plays a role in regulating social behavior. A new University of Virginia study involving brain imaging finds that people with naturally ...




User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here to reset your password.

Sign in to get notified via email when new comments are made.











Katherina Narr, PhD. Credit: UCLA


Although scientists know that depression affects the brain, they don't know why some people respond to treatment while others do not.



Now a team of UCLA researchers has shown for the first time in a large cohort of patients that electroconvulsive therapy (ECT), sometimes referred to as shock , change certain areas of the brain that play a role in how people feel, learn and respond to positive and negative environmental factors. The team imaged the hippocampus and amgydalar in patients before, during and after undergoing ECT and compared those images to healthy control subjects.


They also showed that the hippocampus changes, or increases in size, correlated to improved mood in patients with major depression and indicated how well they were responding to treatment. Additionally, using leading-edge methods to look at brain shape, the team showed that parts of these structures change more with treatment, providing vital clues to how the connections in the brain may be used to select for patients who will respond well to treatment.


That would also result in sparing those patients who won't respond from months of taking drugs that ultimately won't work for them, said study senior author Katherine L. Narr, an associate professor of neurology.


"Major depression is common, affects all ages, races and ethnic groups and has a serious consequence on people's family lives and work," Narr said. "People with depression also are at higher risk for suicide, which accounts for more deaths than car accidents, natural disasters and war each year on average. Unfortunately, standard types of medication used to treat major depression take a long time to work, and for at least a third of people, the medication will not work well enough to provide any real help."


The study appears in the early online edition of the peer-reviewed journal Biological Psychiatry.


ECT, which has been used for more than 50 years, carries with it a certain stigma. However, within the last decade, advances in anesthesia, electrical stimulation equipment and new evidence about electrode lead placement have improved safety and reduced side effects, said study first author Shantanu H. Joshi, an assistant professor of neurology.


Further advances in high-resolution MRI also allow the measurement of the induced brain changes with improved accuracy and precision.


"ECT has been shown to be very effective for treating patients with who don't respond well to other treatments," Joshi said. "During the treatment course, ECT leads to plastic changes in the brain that are linked with improvements in mood. Specifically, we saw the hippocampus and amygdala - important for memory and emotion - are shown to increase in size. People with smaller hippocampal size prior to starting treatment are less likely to respond as well to treatment. While our research investigates structural neuroplasticity in depression in response to ECT, our findings are considered to be of much broader interest to the field."


In addition to ECT, the team expects that the effects shown would extend to more standard, less rapidly acting antidepressant treatments and could be used to predict patient response.


In this study, the team imaged 43 patients undergoing ECT at three time points, before beginning treatment, after the second ECT session and within one week of completing treatment, resulting in 129 brain scans. They also imaged 32 healthy controls twice, and compared those images to the ECT patients.


Going forward, the UCLA team will examine the relationship between the hippocampal structural neuroplasticity and its neurochemistry in terms of the metabolite response, which has important implications for understanding the brain's metabolic regulation and the excitation and suppression as a response to ECT. Additionally, the hippocampal and amgydalar shape will be used as features for classification and prediction of depression diagnosis and treatment response using advanced machine-learning techniques. The changes in the hippocampal and the amgydalar structure will be further investigated with regards to novel disease maintenance treatments along with relapse/recurrence rates.


Major affects 350 million people each year and leads to enormous personal suffering, loss of productivity and is aburden to family, the health care system and the economy. Finding better ways to select patients for treatments that will alleviate their symptoms would go a long way to reducing that suffering, Narr said.


"Our findings newly show that hippocampal structure prior to ECT may be an important indicator of treatment outcome," the study states. "That is, with smaller hippocampal volumes at baseline are shown to more likely exhibit increases in volume with ECT and to show concomitant improvements in clinical symptoms. Results further indicate that both clinical response to ECT and ECT-induced changes in volume occur rapidly."



Medical Xpress on facebook


Related Stories


Researchers look at therapeutic benefits of ketamine


date May 01, 2013

The largest trial into the use of Electroconvulsive Therapy (ECT) in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe ...



Declining access to electroconvulsive therapy: A clinical choice or an economic one?


date Jan 10, 2013

Horrific images from One Flew Over the Cuckoo's Nest notwithstanding, modern electroconvulsive therapy (ECT) remains one of the safest and most effective antidepressant treatments, particularly for patients who do not tolerate ...



New depression treatment may avoid side effects


date Oct 23, 2012

In an Australian first, researchers are studying Magnetic Seizure Therapy (MST) as an alternative treatment for the 30 per cent of patients suffering from depression who don't respond to traditional treatment.



Researchers find ECT can rid the mind of selected memory


date Dec 23, 2013

(Medical Xpress)—A team of researchers working in the Netherlands has found that partial selective memory deletion can be achieved using Electroconvulsive Therapy (ECT). In their paper published in the journal ...



ECT can restore quality of life for some severely depressed patients


date Apr 15, 2013

Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.





Recommended for you



Publication bias and 'spin' raise questions about drugs for anxiety disorders


date 22 minutes ago

A new analysis reported in JAMA Psychiatry raises serious questions about the increasingly common use of second-generation antidepressant drugs to treat anxiety disorders.




What is the best measure of depression severity in adolescents?


date 4 hours ago

At present the key symptom for diagnosing major depressive disorder (MDD) in adolescents is irritability. However a new study has found that the severity of anhedonia (the inability to gain pleasure from ...




Classroom behaviour and dyslexia research


date 6 hours ago

Bournemouth University lecturer Dr Julie Kirkby is investigating the significance of copying and note-taking in the classroom and how it affects the learning of Dyslexic children.




We all feel disgust but why do some of us turn it on ourselves?


date 6 hours ago

Disgust is a universal emotion – we all get disgusted by things, just as we all experience other "basic" emotions, such as happiness and sadness. Disgust has many functions. It protects us from products ...




Study finds vast regional differences in personality within the UK


date 7 hours ago

How exactly do we become the people we are? A study published earlier this week found that there are vast regional differences in personality within the UK. ...




Hormone level predicts how the brain processes social information


date 7 hours ago

The hormone oxytocin is made at different levels in different people and it plays a role in regulating social behavior. A new University of Virginia study involving brain imaging finds that people with naturally ...




User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here

to reset your password.


Sign in to get notified via email when new comments are made.











Categories:

0 comments:

Post a Comment